TrialBreast cancer research and treatment2012

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer.

Robert W Carlson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.